[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global CIS Insulin Market Report (Status and Outlook)

October 2018 | 119 pages | ID: 27945CAD70FEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global CIS Insulin market for 2018-2023.

Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.
Over the next five years, LPI(LP Information) projects that CIS Insulin will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of CIS Insulin market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Long-Acting Analog
  • Rapid Acting Analog
  • Intermediate Insulin
  • Short Acting Insulin
  • Premixed Insulin
Segmentation by application:
  • Type I and Other Diabetes
  • Type II Diabetes
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Eli Lilly
  • Novo Nordisk
  • Takeda Pharmaceuticals
  • Sanofi Aventis
  • Nanjing Xinbai Pharmaceutical
  • Oramed Pharmaceuticals
  • Merck
  • Boehringer Ingelheim
  • Biocon
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global CIS Insulin market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of CIS Insulin market by identifying its various subsegments.
  • Focuses on the key global CIS Insulin players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the CIS Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of CIS Insulin submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CIS Insulin Market Size 2013-2023
  2.1.2 CIS Insulin Market Size CAGR by Region
2.2 CIS Insulin Segment by Type
  2.2.1 Long-Acting Analog
  2.2.2 Rapid Acting Analog
  2.2.3 Premixed Analog
  2.2.4 Intermediate Insulin
  2.2.5 Short Acting Insulin
  2.2.6 Premixed Insulin
2.3 CIS Insulin Market Size by Type
  2.3.1 Global CIS Insulin Market Size Market Share by Type (2013-2018)
  2.3.2 Global CIS Insulin Market Size Growth Rate by Type (2013-2018)
2.4 CIS Insulin Segment by Application
  2.4.1 Type I and Other Diabetes
  2.4.2 Type II Diabetes
2.5 CIS Insulin Market Size by Application
  2.5.1 Global CIS Insulin Market Size Market Share by Application (2013-2018)
  2.5.2 Global CIS Insulin Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CIS INSULIN BY PLAYERS

3.1 Global CIS Insulin Market Size Market Share by Players
  3.1.1 Global CIS Insulin Market Size by Players (2016-2018)
  3.1.2 Global CIS Insulin Market Size Market Share by Players (2016-2018)
3.2 Global CIS Insulin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CIS INSULIN BY REGIONS

4.1 CIS Insulin Market Size by Regions
4.2 Americas CIS Insulin Market Size Growth
4.3 APAC CIS Insulin Market Size Growth
4.4 Europe CIS Insulin Market Size Growth
4.5 Middle East & Africa CIS Insulin Market Size Growth

5 AMERICAS

5.1 Americas CIS Insulin Market Size by Countries
5.2 Americas CIS Insulin Market Size by Type
5.3 Americas CIS Insulin Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC CIS Insulin Market Size by Countries
6.2 APAC CIS Insulin Market Size by Type
6.3 APAC CIS Insulin Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe CIS Insulin by Countries
7.2 Europe CIS Insulin Market Size by Type
7.3 Europe CIS Insulin Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CIS Insulin by Countries
8.2 Middle East & Africa CIS Insulin Market Size by Type
8.3 Middle East & Africa CIS Insulin Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CIS INSULIN MARKET FORECAST

10.1 Global CIS Insulin Market Size Forecast (2018-2023)
10.2 Global CIS Insulin Forecast by Regions
  10.2.1 Global CIS Insulin Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global CIS Insulin Forecast by Type
10.8 Global CIS Insulin Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Company Details
  11.1.2 CIS Insulin Product Offered
  11.1.3 Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Eli Lilly News
11.2 Novo Nordisk
  11.2.1 Company Details
  11.2.2 CIS Insulin Product Offered
  11.2.3 Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Novo Nordisk News
11.3 Takeda Pharmaceuticals
  11.3.1 Company Details
  11.3.2 CIS Insulin Product Offered
  11.3.3 Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Takeda Pharmaceuticals News
11.4 Sanofi Aventis
  11.4.1 Company Details
  11.4.2 CIS Insulin Product Offered
  11.4.3 Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Sanofi Aventis News
11.5 Nanjing Xinbai Pharmaceutical
  11.5.1 Company Details
  11.5.2 CIS Insulin Product Offered
  11.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Nanjing Xinbai Pharmaceutical News
11.6 Oramed Pharmaceuticals
  11.6.1 Company Details
  11.6.2 CIS Insulin Product Offered
  11.6.3 Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Oramed Pharmaceuticals News
11.7 Merck
  11.7.1 Company Details
  11.7.2 CIS Insulin Product Offered
  11.7.3 Merck CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Merck News
11.8 Boehringer Ingelheim
  11.8.1 Company Details
  11.8.2 CIS Insulin Product Offered
  11.8.3 Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Boehringer Ingelheim News
11.9 Biocon
  11.9.1 Company Details
  11.9.2 CIS Insulin Product Offered
  11.9.3 Biocon CIS Insulin Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Biocon News

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of CIS Insulin
Figure CIS Insulin Report Years Considered
Figure Market Research Methodology
Figure Global CIS Insulin Market Size Growth Rate 2013-2023 ($ Millions)
Table CIS Insulin Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Long-Acting Analog
Table Major Players of Rapid Acting Analog
Table Major Players of Premixed Analog
Table Major Players of Intermediate Insulin
Table Major Players of Short Acting Insulin
Table Major Players of Premixed Insulin
Table Market Size by Type (2013-2018) ($ Millions)
Table Global CIS Insulin Market Size Market Share by Type (2013-2018)
Figure Global CIS Insulin Market Size Market Share by Type (2013-2018)
Figure Global Long-Acting Analog Market Size Growth Rate
Figure Global Rapid Acting Analog Market Size Growth Rate
Figure Global Premixed Analog Market Size Growth Rate
Figure Global Intermediate Insulin Market Size Growth Rate
Figure Global Short Acting Insulin Market Size Growth Rate
Figure Global Premixed Insulin Market Size Growth Rate
Figure CIS Insulin Consumed in Type I and Other Diabetes
Figure Global CIS Insulin Market: Type I and Other Diabetes (2013-2018) ($ Millions)
Figure Global Type I and Other Diabetes YoY Growth ($ Millions)
Figure CIS Insulin Consumed in Type II Diabetes
Figure Global CIS Insulin Market: Type II Diabetes (2013-2018) ($ Millions)
Figure Global Type II Diabetes YoY Growth ($ Millions)
Table Global CIS Insulin Market Size by Application (2013-2018) ($ Millions)
Table Global CIS Insulin Market Size Market Share by Application (2013-2018)
Figure Global CIS Insulin Market Size Market Share by Application (2013-2018)
Figure Global CIS Insulin Market Size in Type I and Other Diabetes Growth Rate
Figure Global CIS Insulin Market Size in Type II Diabetes Growth Rate
Table Global CIS Insulin Revenue by Players (2016-2018) ($ Millions)
Table Global CIS Insulin Revenue Market Share by Players (2016-2018)
Figure Global CIS Insulin Revenue Market Share by Players in 2017
Table Global CIS Insulin Key Players Head office and Products Offered
Table CIS Insulin Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global CIS Insulin Market Size by Regions 2013-2018 ($ Millions)
Table Global CIS Insulin Market Size Market Share by Regions 2013-2018
Figure Global CIS Insulin Market Size Market Share by Regions 2013-2018
Figure Americas CIS Insulin Market Size 2013-2018 ($ Millions)
Figure APAC CIS Insulin Market Size 2013-2018 ($ Millions)
Figure Europe CIS Insulin Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa CIS Insulin Market Size 2013-2018 ($ Millions)
Table Americas CIS Insulin Market Size by Countries (2013-2018) ($ Millions)
Table Americas CIS Insulin Market Size Market Share by Countries (2013-2018)
Figure Americas CIS Insulin Market Size Market Share by Countries in 2017
Table Americas CIS Insulin Market Size by Type (2013-2018) ($ Millions)
Table Americas CIS Insulin Market Size Market Share by Type (2013-2018)
Figure Americas CIS Insulin Market Size Market Share by Type in 2017
Table Americas CIS Insulin Market Size by Application (2013-2018) ($ Millions)
Table Americas CIS Insulin Market Size Market Share by Application (2013-2018)
Figure Americas CIS Insulin Market Size Market Share by Application in 2017
Figure United States CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Canada CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Mexico CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Table APAC CIS Insulin Market Size by Countries (2013-2018) ($ Millions)
Table APAC CIS Insulin Market Size Market Share by Countries (2013-2018)
Figure APAC CIS Insulin Market Size Market Share by Countries in 2017
Table APAC CIS Insulin Market Size by Type (2013-2018) ($ Millions)
Table APAC CIS Insulin Market Size Market Share by Type (2013-2018)
Figure APAC CIS Insulin Market Size Market Share by Type in 2017
Table APAC CIS Insulin Market Size by Application (2013-2018) ($ Millions)
Table APAC CIS Insulin Market Size Market Share by Application (2013-2018)
Figure APAC CIS Insulin Market Size Market Share by Application in 2017
Figure China CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Japan CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Korea CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure India CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Australia CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Table Europe CIS Insulin Market Size by Countries (2013-2018) ($ Millions)
Table Europe CIS Insulin Market Size Market Share by Countries (2013-2018)
Figure Europe CIS Insulin Market Size Market Share by Countries in 2017
Table Europe CIS Insulin Market Size by Type (2013-2018) ($ Millions)
Table Europe CIS Insulin Market Size Market Share by Type (2013-2018)
Figure Europe CIS Insulin Market Size Market Share by Type in 2017
Table Europe CIS Insulin Market Size by Application (2013-2018) ($ Millions)
Table Europe CIS Insulin Market Size Market Share by Application (2013-2018)
Figure Europe CIS Insulin Market Size Market Share by Application in 2017
Figure Germany CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure France CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure UK CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Italy CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Russia CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Spain CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa CIS Insulin Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa CIS Insulin Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa CIS Insulin Market Size Market Share by Countries in 2017
Table Middle East & Africa CIS Insulin Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa CIS Insulin Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa CIS Insulin Market Size Market Share by Type in 2017
Table Middle East & Africa CIS Insulin Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa CIS Insulin Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa CIS Insulin Market Size Market Share by Application in 2017
Figure Egypt CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure South Africa CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Israel CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Turkey CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries CIS Insulin Market Size Growth 2013-2018 ($ Millions)
Figure Global CIS Insulin arket Size Forecast (2018-2023) ($ Millions)
Table Global CIS Insulin Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global CIS Insulin Market Size Market Share Forecast by Regions
Figure Americas CIS Insulin Market Size 2018-2023 ($ Millions)
Figure APAC CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Europe CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa CIS Insulin Market Size 2018-2023 ($ Millions)
Figure United States CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Canada CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Mexico CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Brazil CIS Insulin Market Size 2018-2023 ($ Millions)
Figure China CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Japan CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Korea CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Southeast Asia CIS Insulin Market Size 2018-2023 ($ Millions)
Figure India CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Australia CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Germany CIS Insulin Market Size 2018-2023 ($ Millions)
Figure France CIS Insulin Market Size 2018-2023 ($ Millions)
Figure UK CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Italy CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Russia CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Spain CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Egypt CIS Insulin Market Size 2018-2023 ($ Millions)
Figure South Africa CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Israel CIS Insulin Market Size 2018-2023 ($ Millions)
Figure Turkey CIS Insulin Market Size 2018-2023 ($ Millions)
Figure GCC Countries CIS Insulin Market Size 2018-2023 ($ Millions)
Table Global CIS Insulin Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global CIS Insulin Market Size Market Share Forecast by Type (2018-2023)
Table Global CIS Insulin Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global CIS Insulin Market Size Market Share Forecast by Application (2018-2023)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Eli Lilly CIS Insulin Market Share (2016-2018)
Table Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Novo Nordisk CIS Insulin Market Share (2016-2018)
Table Takeda Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Takeda Pharmaceuticals CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Takeda Pharmaceuticals CIS Insulin Market Share (2016-2018)
Table Sanofi Aventis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Aventis CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Sanofi Aventis CIS Insulin Market Share (2016-2018)
Table Nanjing Xinbai Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Nanjing Xinbai Pharmaceutical CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Nanjing Xinbai Pharmaceutical CIS Insulin Market Share (2016-2018)
Table Oramed Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oramed Pharmaceuticals CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Oramed Pharmaceuticals CIS Insulin Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Merck CIS Insulin Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim CIS Insulin Market Share (2016-2018)
Table Biocon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocon CIS Insulin Revenue and Gross Margin (2016-2018)
Figure Biocon CIS Insulin Market Share (2016-2018)


More Publications